TruScreen: So this is different; a med-tech product with actual sales!
Listen to ASX-listed TruScreen CEO Beata Edling talk to Matt Birney on the Bulls N’ Bears Report about TruScreen’s truly disruptive cervical cancer screening device and the burgeoning demand coming from one of the most populous countries on the planet.